US2022221446A1PendingUtilityA1
Methods for Detecting Symmetrical Dimethylarginine
Est. expiryAug 7, 2028(~2 yrs left)· nominal 20-yr term from priority
G01N 33/6812C07K 16/44C07C 279/12A61P 13/12G01N 33/53G01N 33/54366
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Method of detecting Symmetrical dimethyl arginine (SDMA) in biological samples. SDMA analogs for generating anti-SDMA antibodies having little or no cross-reactivity with asymmetrical dimethyl arginine, arginine, and monomethylarginine. The analogs have a protected or free thiol (—SH) group or hydroxyl (—OH) group that allow them to be linked to a suitable conjugation target which can be, for example, a protein containing molecule of a label. The anti-SDMA antibodies can be used in diagnostic immunoassay for the diagnosis of SDMA associated disorders and/or diseases.
Claims
exact text as granted — not AI-modified1 . A device for determining the presence of free symmetrical dimethylarginine (SDMA) in a sample, the device comprising an SDMA analog attached to a solid phase.
2 . The device of claim 1 , further comprising unbound free SDMA from a patient sample on the solid phase.
3 . The device of claim 2 , wherein the SDMA analog is attached to the solid phase through a carboxyl group (—CO(OH)) on SDMA.
4 . The device of claim 3 , wherein a hydroxyl (OH) group of the carboxyl group (—CO(OH)) on SDMA is converted to an amide bond (—CO(NH—)) when conjugated.
5 . The device of claim 1 , wherein the SDMA analog is selected from the group consisting of:
wherein x and y are integers ranging from 1 to 5.Join the waitlist — get patent alerts
Track US2022221446A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.